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unobserved selectivity, a condition not satisﬁed in many
retrospective healthcare studies, especially those based on
administrative claims databases.
PMD5
IMPROVING REPORTS OF PRO DATA TO
SUPPORT AN EFFECTIVENESS CLAIM
Marquis P1, Piault E1,Abetz L2,Arnould B3
1Mapi Values, Boston, MA, USA; 2Mapi Values, Cheshire, UK;
3Mapi Values, Lyon, France
OBJECTIVES: The same standards should apply for 
measuring patient reported outcomes (PRO) as for any
clinical measure used for an effectiveness claim. Yet, dis-
crepancies between the number of submissions and the
number of PRO claims granted illustrate how difﬁcult it
is to demonstrate the “substantial evidence” required by
authorities. Reporting PRO data separately from the clin-
ical data makes reviewing PRO claims difﬁcult. However,
International Conference Harmonization (ICH) guide-
lines provide no standard location for PRO measurement
information. Better integration of PRO data in clinical
reports and standardized documentation of PRO mea-
sures would improve the reviewing process and enhance
the likelihood of securing claims. We will present the
value of implementing a standardized approach to docu-
menting PRO measures in regulatory submission reports.
METHODS: Our recommendations are based on ICH
guidelines and the ERIQA and PRO Harmonization
group recommendations. While current ICH report
guidelines provide no headings for documenting back-
ground information on PRO measures, appropriate head-
ings can be added to report PRO methods and ﬁndings
as part of the primary clinical trial report without 
modifying the ICH numbering system. However, the
questionnaire development and validation relevant to 
the condition and treatment considered are better located
in supporting appendices as are reviews of literature 
documenting the use and interpretation of data collected
with it. RESULTS: These appendices should include evi-
dence of the clinical signiﬁcance of differences to help
reviewers familiarize themselves with the instrument.
CONCLUSION: Better integration of PRO in clinical
study report guidelines and the development of a speciﬁc
system for standardized documentation of PRO measures
will enhance transparency and acceptance of PRO data,
and thereby increase the acceptance by decision-makers
of effectiveness claims based on PRO.
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ESTIMATING THE TRAJECTORY-ADJUSTED
IMPACT OF ACUTE EVENTS ON 
PATIENT-REPORTED OUTCOMES
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OBJECTIVES: To establish clinical meaningfulness of
effect sizes and validate measures of patient-reported out-
comes (PROs), it is important to understand the effect of
acute clinical events on PROs. When PROs are measured
before and after an acute event, there are several options
for measuring change. This example illustrates the beneﬁt
of adjusting estimates of change for patients’ pre-event
trajectories. METHODS: To determine the effect of
pathologic fractures (PF) on PROs, we used data from a
clinical trial of zoledronic acid versus placebo in patients
with prostate cancer (N = 643). Only patients who expe-
rienced a PF were included in this analysis (n = 76). 
For illustrative purposes, the Functional Assessment of
Cancer Therapy-General (FACT-G) total score was com-
pared before and after each patient’s ﬁrst PF using two
methods: 1) estimate simple mean change from pre-PF
value to post-PF value and perform a paired t-test; and
2) use a linear mixed effects model to analyze all time
points from baseline to the ﬁrst time point after the PF,
with a dummy variable indicating the pre-PF (0) and post-
PF (1) status. The ﬁxed-effect for the dummy variable is
the trajectory-adjusted mean change (TAMC). (Note:
analyses not reported here showed signiﬁcant effects of
PF on three of the four FACT subscales). RESULTS: The
simple mean change was -4.03 (SD = 13.57), which was
signiﬁcant by a paired t-test (p = 0.04). The TAMC,
however, was -2.00 (95% CI = -5.53, 1.52), and was not
statistically signiﬁcant (p = 0.26). CONCLUSIONS: In
assessing the impact of acute events on PROs, simple 
pre-post comparisons may misestimate effect size and/or
statistical signiﬁcance. The mixed-effects model presented
here more accurately assesses changes in PROs by adjust-
ing for the pre-event trajectory due to prostate cancer
with bone metastases, isolating the change in PROs
attributable to the acute clinical event.
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THE CONGRUENCE OF SELF-REPORT WITH
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ADHERENCE:A SUMMARY OF THE LITERATURE
Garber M, Nau DP, Erickson SR
University of Michigan, Ann Arbor, MI, USA
OBJECTIVES: The objective of this paper is to deter-
mine the congruence of self-report measures of medica-
tion adherence with other measures of adherence.
METHODS: A literature search was conducted across
1978–2002. MEDLINE, PsychInfo, IPA and ISI databases
were used to identify studies that met the following inclu-
sion criteria: 1) study included at least one self-report
measure and one non-self-report measure of adherence;
2) data were reported that would allow a comparison of
the measures (e.g., individual scores or a correlation/con-
cordance statistic); and 3) the report was in English. The
studies were categorized by type of self-report adherence
measure (questionnaire, diary, interview) and by type 
of non-self-report method (administrative claims, pill
count/canister weight, biological assay, electronic mea-
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sures, or third-party opinion). The congruence of the
adherence measures was classiﬁed as high, medium or
low. This allowed a comparison of the congruence
between categories of adherence measures. RESULTS:
Eighty-four studies were identiﬁed that met the inclusion
criteria. The distribution of self-report measures were:
interview (n = 48), questionnaire (n = 22), diary (n = 14).
The non-self-report methods were: electronic measures (n
= 29), pill count/canister weight (n = 22), biological assays
(n = 17), claims (n = 10) and third-party opinion (n = 6).
There was substantial variation in the pattern of congru-
ence across the different types of self-report measures.
Interviews had the poorest congruence with other mea-
sures of adherence (only 15 of 48 comparisons found high
congruence). Diaries and Questionnaires were more likely
to exhibit high congruence with other measures (10 of 14
studies, and 12 of 22 studies, respectively). Only 5 of 
the 29 studies involving electronic measures reported 
high congruence with self-reports, although the other
non-self-report measures were often highly congruent
with self-report (32 of 53 studies). CONCLUSION: The 
congruence of self-report and other measures of medica-
tion adherence varies widely based upon the type of
measure.
PMD8
PATIENT SAFETY RESEARCH:A DISCUSSION
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AND A CONCEPTUAL MODEL FOR ADVERSE
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Terminology and conceptual causation models in patient
safety research arose separately in the ﬁelds of human
factors, epidemiology, engineering risk management, and
drug safety; they are confusing and conﬂict with one
another. Much of the terminology perpetuates undesir-
able concepts, such as implicit determination of causa-
tion, and poorly ﬁts an important arena, safety of medical
devices. OBJECTIVES: To review and propose terminol-
ogy and to propose a conceptual model for interpreting
research and designing interventions to reduce confusion
and enhance understanding and communication in this
area. METHODS: We systematically reviewed the termi-
nology used in scientiﬁc literature, discussed the mean-
ings, and made proposals. We also reviewed existing
models and proposed one that enhances the models that
are in the literature. RESULTS: We propose a set of terms
and deﬁnitions for “error,” “hazard,” “adverse event,”
“preventable adverse event,” “potential adverse event,”
and “risk.” The terms and their deﬁnitions are as neutral
as possible with respect to “blame issues” such as
“responsibility,” “negligence,” and “intentionality.” We
also proposed a model that builds on these ideas and on
Rothman’s “causal pie” concept. The concepts allow
explicit recognition of partial, rather than full, under-
standing of hazardous situations. CONCLUSIONS:
The proposed terms, deﬁnitions, and model could clarify
thought, research design and interpretation, the process
of designing and evaluating patient safety interventions,
and communication between interested parties, including
researchers, laypersons, healthcare providers, and risk
managers.
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OBJECTIVES: To assess the level of user acceptance for
an Internet-based methodology for collecting patient out-
comes data from an observational multi-site postmarket
study gathering data from community based ophthalmic
practices. METHODS: The study coordinator at each
participating site (N = 41) was issued an ID & Password
for logging onto the secure and conﬁdential site. Training
of the study coordinators on how to use the site and
patient conﬁdentiality considerations took about 30
minutes. Two sets of questions were being asked: Physi-
cian Questions (8 baseline, 4 followup) and Patient Ques-
tions (9 baseline, 18 followup). Patients were followed for
approximately six months. A small honorarium in return
for completing the study documents was paid. Both glau-
coma speciﬁc clinical & QOL data was collected and 
analyzed. RESULTS: Forty-one sites registered 360
patients for the study. Final follow-up data was entered
on 318 of the 360 registered patients (88%) using the
web-based case report forms. Eighty-seven percent
(36/41) responded to a user survey and all respondents
100% (36/36) felt the system was simple and east to use.
Several users were so enthusiastic they gave text quotes
of additional positive praise on the survey. Many indi-
cated they actually enjoyed participating. CONCLU-
SIONS: Internet-based post-market studies are a
promising methodology for the beneﬁt of both the study
sponsor and participating sites.
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OBJECTIVE: Evaluate the quality of retrospective study
design posters presented at the ISPOR Seventh Annual
Meeting using the criteria published by the ISPOR Task
Force on Retrospective Databases. METHODS: Of the
337 posters presented at the conference, we had access to
133 (39%) from on site collection or the ISPOR website.
These 133 posters were categorized into one of 5 cate-
